Bioperfectus Successfully Expanded the Business to Over 50 Countries Around the World

Company news

We Bioperfectus are proud to announce that Bioperfectus products and service have been successfully expanded to over 50 countries around the globe since the establishment of International Sales & Marketing Division in June, 2020.


We strongly believe that prior success breeds new success. We are looking forward to bringing our diagnostic solution to more and more countries and make the world a healthier place for our generations and generations to come.


Where our next market goes to? 


Be part of our global distribution network, contact us via



Bioperfectus Emergency Response to the Unknown Hepatitis in Children

On 15 April 2022, the World Health Organization (WHO) published an alert on severe acute hepatitis cases of unknown origin in children in the United Kingdom. Since then, there have been continuing additional reports of cases.


Compact and Powerful, SSNP-2000B Promotes Molecular Detection Ability

After SSNP-2000B got the IF award, its application in nucleic acid detection grew with stronger momentum. Conquering the judges with exclusive features, SSNP-2000B also obtained more and more recognition from clinical operators.


Stop Loss from A Small Bite

Vectors are living organisms that can transmit infectious pathogens between humans, or from animals to humans. When a vector becomes infectious, it can transmit the pathogen for the rest of its life during each subsequent bite/blood meal.